Core Viewpoint - The strategic partnership between Meizhong Jiahe (02453) and AIA Hong Kong & Macau aims to enhance the health and wellness of employees through affordable cancer proton therapy and health check programs for eligible insured members [1] Group 1: Partnership Details - Meizhong Jiahe has announced a strategic cooperation with AIA Hong Kong & Macau [1] - The partnership allows eligible insured members of AIA Hong Kong & Macau's group insurance to access affordable cancer proton treatment and health check plans at the flagship institution "Guangzhou Taihe Cancer Hospital" [1] Group 2: Strategic Implications - This collaboration reflects AIA Hong Kong & Macau's commitment to improving overall employee health and wellness under its "AIA Friendly Workplace Life Plan" [1] - The partnership marks a significant step in Meizhong Jiahe's strategic layout in the health ecosystem, providing comprehensive and high-quality cancer and health-related services [1]

Group 1 - The core point of the article is the strategic partnership between Meizhong Jiahe (02453) and AIA Hong Kong and Macau, aimed at enhancing health services for eligible insured members [1] - Under this collaboration, eligible members of AIA's group insurance will have access to more affordable proton therapy and health check plans at the flagship institution "Guangzhou Taihe Cancer Hospital" [1] - This partnership reflects AIA Hong Kong and Macau's commitment to improving employee health and well-being through its "AIA Friendly Workplace Life Plan" [1] Group 2 - The collaboration marks a significant step in the company's strategic layout in the health ecosystem [1] - It aims to provide comprehensive and high-quality cancer and health-related services to eligible insured members of AIA Hong Kong and Macau [1]

格隆汇9月16日丨美中嘉和(02453.HK)宣布，近期公司与友邦保险(国际)有限公司的香港及澳门分行达 成战略合作。在此项合作下，友邦香港及澳门的指定团体保险的合资格受保成员，可于集团的旗舰机构 「广州泰和肿瘤医院」享有更可负担的指定癌症质子治疗及健康检查计划。此项合作体现了友邦香港及 澳门的「AIA友好职场人生计划」下致力提升雇员的整体健康福祉的策略。此项合作也标志着公司在健 康生态领域的战略布局迈出关键一步，及为友邦香港及澳门的指定团体保险的合资格受保成员带来全面 及优质的癌症和健康相关的服务。 ...

美中嘉和醫學技術發展集團股份有限公司 CONCORD HEALTHCARE GROUP CO., LTD. （於中華人民共和國註冊成立的股份有限公司） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致之任何損失承擔任何責任。 在此項合作下，友邦香港及澳門之指定團體保險的合資格受保成員，可於本集團 的旗艦機構「廣州泰和腫瘤醫院」享有更可負擔的指定癌症質子治療及健康檢查計 劃。此項合作體現了友邦香港及澳門的「AIA友好職場人生計劃」下致力提升僱員 的整體健康福祉之策略。此項合作也標誌著本公司在健康生態領域的戰略佈局邁 出關鍵一步，及為友邦香港及澳門之指定團體保險的合資格受保成員帶來全面及 優質的癌症和健康相關的服務。 本公司股東及潛在投資者於買賣本公司股份時務請審慎行事。 承董事會命 美中嘉和醫學技術發展集團股份有限公司 董事長兼執行董事 楊建宇 中國北京，2025年9月16日 於本公告日期，董事會包括(i)執行董事楊建宇博士、付驍女士及常亮先生；(ii)非 執行董事王雷先生、宋 ...